The company is showcasing new development solutions and advanced digital technologies including its new OSD Express and Steriles Express solutions for drug development.
News|Articles|January 9, 2020
IFPAC to Host 34th Annual Conference
Author(s)Pharmaceutical Technology Editors
The event is set to take place from Feb. 23–26, 2020 at the Bethesda North Marriott in North Bethesda, Maryland.
Advertisement
IFPAC will host its 34th annual international forum for process analytical technology from Feb. 23–26, 2020 at the Bethesda North Marriott in North Bethesda, Maryland.
The event kicks off with a regulatory workshop hosted by regulatory and industry leaders regarding Regulatory Approaches to Advanced Process Control on Feb. 23 in the afternoon. The plenary session on manufacturing intelligence will feature presentations from industry, government, and academia, which will lead into over 40 concurrent sessions covering research, technological advances, case studies, and the latest in regulatory guidance, standards, and controls. Topics include analytical methods, particle characterization, Industry 4.0 strategies, digital transformation, data and knowledge management, quality risk management, control strategies, PAT tools for peptides and oligonucleotides, cell and gene therapies, and continuous manufacturing in both biologics and solid-dosage pharmaceuticals.
The annual conference will also feature an exhibition of process analysis and control equipment, poster sessions, and social events for attendees. Pre-conference short courses will be held the morning of Feb. 23.
Source:
Advertisement
Related to this article
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Shadow AI and vendor data retention put GMP records and trade secrets at risk. AI Pulse Check panelists outline what pharma AI policies require.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Advertisement
Advertisement